Lanean...
The Past and the Future of Alzheimer’s Disease Fluid Biomarkers(1)
Following the development of the first methods to measure the core Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarkers total-tau (T-tau), phosphorylated tau (P-tau) and the 42 amino acid form of amyloid-β (Aβ(42)), there has been an enormous expansion of this scientific research area. Toda...
Gorde:
| Argitaratua izan da: | J Alzheimers Dis |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
IOS Press
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5869995/ https://ncbi.nlm.nih.gov/pubmed/29562534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-170773 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|